Bill Anderson/LinkedIn

Nov 26, 2025, 11:37

Bill Anderson on Secondary Stroke Prevention: This Week, We’ve Reached a Significant Milestone

Bill Anderson, CEO at Bayer, shared on LinkedIn:

”Those numbers tell the story: stroke is devastating.

For patients. For families.

And after surviving, the risk of another stroke is even higher.

This week, we’ve reached a significant milestone with positive topline results from our international Phase III study in secondary stroke prevention.

Our teams worked hard to get here.

Thank you, Team Bayer, for pushing to help people who’ve already been through so much.

We’re making progress—and there’s more to do.”

Bill Anderson on Secondary Stroke Prevention: This Week, We've Reached a Significant Milestone

Stay updated with Hemostasis Today.

Bayer Bill Anderson Health Hematology Hemostasis Hemostasis Today Medicine stroke stroke prevention thrombosis

'

'

Managing Thrombotic Risk in Pregnancy

'

Targeted Thrombolysis Beyond tPA

'

'

10 Posts Not to Miss This Week

Hemostasis Today